Rottapharm stake sale scuttled by family owners; EU antitrust officials cite Lundbeck, Merck KGaA;

 @FiercePharma: U.K.'s rolling out flu vax program for all kids, using AstraZeneca's spray immunization. Report | Follow @FiercePharma

> Italy's Rovati family has said "no sale" to private equity firms Avista and Clessidra, which had been negotiating for a 50% stake in their drug firm Rottapharm. Story

> European antitrust regulators charged Denmark's Lundbeck, Germany's Merck KGaA and 7 other companies with violating competition law in blocking cheap knockoffs from the market; Lundbeck denied the allegations. Report

> Strong sales of its multiple sclerosis drug Avonex fueled a profits increase at Biogen Idec ($BIIB). More

> Bayer's Xarelto bloodthinner won final approval from the U.K.'s cost-effectiveness watchdogs for use in deep vein thrombosis and pulmonary embolism. Report

> The Indian government appears to be backing away from new restrictions on foreign investment in the pharma industry. Article

> China is eyeing additional healthcare reforms after expanding services led to rapidly increasing costs, in part because of an epidemic of Western-style chronic disease. Report

> Natco Pharma is set to launch its version of the stomach-acid drug Prevacid in three to four months, its CEO said. Report

Biotech News

 @FierceBiotech: Sanofi sets out to reinvent itself in Genzyme's biotech image. More | Follow @FierceBiotech

 @JohnCFierce: Busy biotech investor NEA unveils $2.6B global fund--says venture money controlled by a smaller number of global players. Story | Follow @JohnCFierce

 @RyanMFierce: China market may grow faster than U.S. for trials tech eClinical, but I don't see that hurting U.S. software cos. Article | Follow @RyanMFierce

> ThromboGenics jolted with safety questions on eve of FDA panel review. News

> Busy biotech investor NEA unveils $2.6B global fund. Report

> Rusnano, Domain team top up CoDa venture round with $20M. Article

> Bluebird adds $60M venture haul to finance pivotal gene therapy study. Story

Medical Device News

@FierceMedDev: Now that SCOTUS has upheld the national health reform law, winners and losers are lining up. Slideshow | Follow @FierceMedDev

 @MarkHFierce: NEA closes its massive VC fund--the 14th--with $2.6 billion in committed capital. Release | Follow @MarkHFierce

 @DamianFierce: Thermo Fisher posts 9% Q2 revenue growth on strong diagnostics sales. Story | Follow @DamianFierce

> Angioplasty with nitinol stents shows promise as PAD treatment. Item

> Edwards scores Q2 growth on heart valve sales. News

Drug Delivery News

> Chiasma closes multimillion funding to support oral acromegaly trial. Story

> Trials enlist vaginal gel and ring in fight against HIV. Article

> Taking insulin could be as simple as moisturizing. News

> Microneedles deliver drugs where eyedrops can't. More

Biomarkers News

> Genetic markers pinpoint medulloblastoma as four diseases, not one. News

> Blood test could predict risk of death from hypertension. Story

> Could markers manage milk allergy? More

> Sodium in the brain marks disability in MS. Article

And Finally... Johnson & Johnson ($JNJ) is shopping around for ad agencies in a global review. Report